A type 2 diabetes clinical study from Karolinska Institutet showed lower blood glucose when using remote diabetes care system with patient app.
The main finding reported by Professor Kerstin Brismar from Karolinska Institutet showed that by using the Triabetes smartphone app and TriabetesClinic online decision support service in Type 2 diabetes treatment long-term blood glucose levels could be reduced. The results come from the first six months of a two-year randomized, multicenter clinical study. 226 patients with Type 2 diabetes are taking part in the study. The blood glucose marker HbA1c was significantly lower in patients being managed by the TriabetesClinic system compared with the control group who were not.
“We found that it is clinically worthwhile to use the Triabetes app combined with the TriabetesClinic service to support the patients to improve metabolic control and lower their HbA1c values,” said Kerstin Brismar, Professor of diabetes research at Karolinska Institutet. “Our analysis after six months showed that apps are a viable way to help control type 2 diabetes when the patient shares live data with their doctor or nurse, who in turn use a web-based triage service to monitor, coach and suggest treatment strategies.”
The patients in the study are spread across nine different primary care clinics in Poland run by the managed care group Medicover. The study uses medtech firm Diabetes Tools’ Triabetes smartphone app for patients and TriabetesClinic, a web-based diabetes decision support service, for healthcare providers. The research is backed by academics from the Medical University of Warsaw and Karolinska Institutet in Stockholm, Sweden.
Photo: Kerstin Brismar
Photo credit: Ulf Sirborn